Isabelle Léna

Isabelle Léna

Auto-generated profile, based on publicly available information

Isabelle Léna

Université Côte d’Azur and

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2005 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
ILI. Léna
I. Léna
SPSandrine Parrot
Sandrine Parrot
ODO. Deschaux
O. Deschaux
SMS. Muffat‐Joly
S. Muffat‐Joly
VSV. Sauvinet
V. Sauvinet
CGC. Gottesmann
C. Gottesmann

1 August 2005 in Cell
Verified
Journal Article
Closed access
JGJi-Song Guan
Ji-Song Guan
ZXZhen-Zhong Xu
Zhen-Zhong Xu
HGHua Gao
Hua Gao
SHShao-Qiu He
Shao-Qiu He
GMGuo-Qiang Ma
Guo-Qiang Ma
XZXu Zhang
Xu Zhang

1 October 1998 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Closed access
VDValérie Daugé
Valérie Daugé
ILIsabelle Léna
Isabelle Léna

15 October 2001 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
NFNicolas Froger
Nicolas Froger
AGAlain M. Gardier
Alain M. Gardier
RMRosario Moratalla
Rosario Moratalla
IAIsrael Alberti
Israel Alberti
ILIsabelle Lena
Isabelle Lena
LLLaurence Lanfumey
Laurence Lanfumey
Antagonists at substance P receptors of the neurokinin 1 (NK1) type have been shown to represent a novel class of antidepressant drugs, with comparable clinical efficacy to the selective serotonin (5-HT) reuptake inhibitors (SSRIs). Because 5-HT1Areceptors may be critically involved in the mechanisms of action of SSRIs, we examined whether these receptors could also be affected in a model of whole-life blockade of NK1 receptors, i.e. knock-out mice lacking the latter receptors (NK1−/−). 5-HT1A receptor labeling by the selective antagonist radioligand [3H]N-[2-[4-(2-methoxyphenyl)1-piperazinyl]-ethyl]-N-(2-pyridinyl)-cyclohexanecarboxamide (WAY 100635) and 5-HT1A-dependent [35S]GTP-γ-S binding at the level of the dorsal raphe nucleus (DRN) in brain sections, as well as the concentration of 5-HT1A mRNA in the anterior raphe area were significantly reduced (−19 to −46%) in NK1−/− compared with NK1+/+ mice. Furthermore, a ∼10-fold decrease in the potency of the 5-HT1A receptor agonist ipsapirone to inhibit the discharge of serotoninergic neurons in the dorsal raphe nucleus within brainstem slices, and reduced hypothermic response to 8-OH-DPAT, were noted in NK1−/− versus NK1+/+ mice. On the other hand, cortical 5-HT overflow caused by systemic injection of the SSRI paroxetine was four- to sixfold higher in freely moving NK1−/− mutants than in wild-type NK1+/+ mice. Accordingly, the constitutive lack of NK1 receptors appears to be associated with a downregulation/functional desensitization of 5-HT1A autoreceptors resembling that induced by chronic treatment with SSRI antidepressants. Double immunocytochemical labeling experiments suggest that such a heteroregulation of 5-HT1A autoreceptors in NK1−/− mutants does not reflect the existence of direct NK1–5-HT1A receptor interactions in normal mice.

8 March 2006 in Neuropsychopharmacology
Verified
Journal Article
Closed access
FRFlorence Razoux
Florence Razoux
RGRené Garcia
René Garcia
ILIsabelle Léna
Isabelle Léna

19 June 2006 in Synapse
Verified
Journal Article
Closed access
PDF file
SHSandrine Hugues
Sandrine Hugues
ACAline Chessel
Aline Chessel
ILIsabelle Lena
Isabelle Lena
RMRobert Marsault
Robert Marsault
RGRene Garcia
Rene Garcia